Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2015

BAGSVAERD, Denmark, April 29, 2015 (GLOBE NEWSWIRE) -- In accordance with Section 6 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Referring to Company Announcement no 27/2015 dated 22 April 2015, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 29 April 2015.

Further information

Media:
Anne Margrethe Hauge +45 3079 3450 amhg@novonordisk.com


Investors:
Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com
Daniel Bohsen +45 3079 6376 dabo@novonordisk.com
Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com
Frank Daniel Mersebach (US) +1 609 235 8567 fdni@novonordisk.com

Company announcement No 30 / 2015

Company announcement No 30 / 2015 http://hugin.info/2013/R/1916602/685391.pdf

HUG#1916602

Source:Novo Nordisk A/S